Rankings
▼
Calendar
TEVA Q4 2018 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$36B
Q4 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$4.6B
-16.5% YoY
Gross Profit
$2.0B
43.2% margin
Operating Income
-$3.2B
-69.4% margin
Net Income
-$2.9B
-63.3% margin
EPS (Diluted)
$-2.80
QoQ Revenue Growth
+0.7%
Cash Flow
Operating Cash Flow
$367M
Free Cash Flow
$154M
Stock-Based Comp.
$33M
Balance Sheet
Total Assets
$60.7B
Total Liabilities
$44.9B
Stockholders' Equity
$14.7B
Cash & Equivalents
$1.8B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4.6B
$5.5B
-16.5%
Gross Profit
$2.0B
$2.5B
-22.5%
Operating Income
-$3.2B
-$13.0B
+75.7%
Net Income
-$2.9B
-$11.5B
+75.0%
Revenue Segments
International Markets
$740M
66%
Other Activities
$377M
34%
Geographic Segments
North America
$1.9B
61%
Europe
$1.2B
39%
← FY 2018
All Quarters
Q1 2019 →